151 related articles for article (PubMed ID: 20505648)
1. Daptomycin use in patients with cancer and neutropenia: data from a retrospective registry.
Rolston KV; McConnell SA; Brown J; Lamp KC
Clin Adv Hematol Oncol; 2010 Apr; 8(4):249-56, 90. PubMed ID: 20505648
[TBL] [Abstract][Full Text] [Related]
2. Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.
Moise PA; Hershberger E; Amodio-Groton MI; Lamp KC
Ann Pharmacother; 2009 Jul; 43(7):1211-9. PubMed ID: 19584384
[TBL] [Abstract][Full Text] [Related]
3. Clinical outcomes of patients receiving daptomycin for the treatment of Staphylococcus aureus infections and assessment of clinical factors for daptomycin failure: a retrospective cohort study utilizing the Cubicin Outcomes Registry and Experience.
Sakoulas G; Brown J; Lamp KC; Friedrich LV; Lindfield KC
Clin Ther; 2009 Sep; 31(9):1936-45. PubMed ID: 19843483
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of daptomycin in complicated skin and skin-structure infections due to methicillin-sensitive and -resistant Staphylococcus aureus: results from the CORE Registry.
Martone WJ; Lamp KC
Curr Med Res Opin; 2006 Dec; 22(12):2337-43. PubMed ID: 17257448
[TBL] [Abstract][Full Text] [Related]
5. Daptomycin for the treatment of surgical site infections.
Chamberlain RS; Culshaw DL; Donovan BJ; Lamp KC
Surgery; 2009 Aug; 146(2):316-24. PubMed ID: 19628091
[TBL] [Abstract][Full Text] [Related]
6. Daptomycin in the treatment of bacteremia.
Sakoulas G; Golan Y; Lamp KC; Friedrich LV; Russo R
Am J Med; 2007 Oct; 120(10 Suppl 1):S21-7. PubMed ID: 17904947
[TBL] [Abstract][Full Text] [Related]
7. Daptomycin experience in critical care patients: results from a registry.
Brown JE; Fominaya C; Christensen KJ; McConnell SA; Lamp KC
Ann Pharmacother; 2012 Apr; 46(4):495-502. PubMed ID: 22454446
[TBL] [Abstract][Full Text] [Related]
8. Daptomycin in the treatment of patients with infective endocarditis: experience from a registry.
Levine DP; Lamp KC
Am J Med; 2007 Oct; 120(10 Suppl 1):S28-33. PubMed ID: 17904948
[TBL] [Abstract][Full Text] [Related]
9. Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patients.
Gallagher JC; Perez ME; Marino EA; LoCastro LG; Abrardo LA; MacDougall C
Pharmacotherapy; 2009 Jul; 29(7):792-9. PubMed ID: 19558253
[TBL] [Abstract][Full Text] [Related]
10. Clinical experience with daptomycin for the treatment of patients with documented gram-positive septic arthritis.
Forrest GN; Donovan BJ; Lamp KC; Friedrich LV
Ann Pharmacother; 2008 Feb; 42(2):213-7. PubMed ID: 18212253
[TBL] [Abstract][Full Text] [Related]
11. Clinical experience with daptomycin for the treatment of patients with osteomyelitis.
Lamp KC; Friedrich LV; Mendez-Vigo L; Russo R
Am J Med; 2007 Oct; 120(10 Suppl 1):S13-20. PubMed ID: 17904946
[TBL] [Abstract][Full Text] [Related]
12. Daptomycin for the treatment of enterococcal bacteraemia: results from the Cubicin Outcomes Registry and Experience (CORE).
Mohr JF; Friedrich LV; Yankelev S; Lamp KC
Int J Antimicrob Agents; 2009 Jun; 33(6):543-8. PubMed ID: 19201165
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients.
Chaftari AM; Hachem R; Mulanovich V; Chemaly RF; Adachi J; Jacobson K; Jiang Y; Raad I
Int J Antimicrob Agents; 2010 Aug; 36(2):182-6. PubMed ID: 20452752
[TBL] [Abstract][Full Text] [Related]
14. Daptomycin use in neutropenic patients with documented gram-positive infections.
Rolston KV; Besece D; Lamp KC; Yoon M; McConnell SA; White P
Support Care Cancer; 2014 Jan; 22(1):7-14. PubMed ID: 23975231
[TBL] [Abstract][Full Text] [Related]
15. High-dose daptomycin for treatment of complicated gram-positive infections: a large, multicenter, retrospective study.
Kullar R; Davis SL; Levine DP; Zhao JJ; Crank CW; Segreti J; Sakoulas G; Cosgrove SE; Rybak MJ
Pharmacotherapy; 2011 Jun; 31(6):527-36. PubMed ID: 21923436
[TBL] [Abstract][Full Text] [Related]
16. Safety of daptomycin in patients receiving hemodialysis.
Mueller BA; Crompton JA; Donovan BJ; Yankalev S; Lamp KC
Pharmacotherapy; 2011 Jul; 31(7):665-72. PubMed ID: 21923453
[TBL] [Abstract][Full Text] [Related]
17. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
[TBL] [Abstract][Full Text] [Related]
18. Postmarketing clinical experience in patients with skin and skin-structure infections treated with daptomycin.
Owens RC; Lamp KC; Friedrich LV; Russo R
Am J Med; 2007 Oct; 120(10 Suppl 1):S6-12. PubMed ID: 17904950
[TBL] [Abstract][Full Text] [Related]
19. [Antibiotic treatment of enterococcal infections in gastroenterology with daptomycin - first experiences from the EU-CORE registry study (European Cubicin® Outcomes Registry and Experience)].
Lübbert C; Wilhelms D; Worlitzsch D; Ettrich TJ; Behl S; Seufferlein T
Z Gastroenterol; 2012 Apr; 50(4):373-81. PubMed ID: 22430297
[TBL] [Abstract][Full Text] [Related]
20. Multidrug-resistant gram-positive infections in patients with ventricular assist devices: the role of daptomycin.
Beiras-Fernandez A; Kur F; Kiefer S; Sodian R; Schmoeckel M; Weis M; Reichart B; Weis F
Transplant Proc; 2009; 41(6):2589-91. PubMed ID: 19715980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
